The 15th Conference on Retroviruses and Opportunistic Infections - CROI 2008

The 15th Conference on Retroviruses and Opportunistic Infections was a scientifically focused meeting of the world's leading researchers working to understand, prevent, and treat HIV/AIDS and its complications.
At the Conference which took place from February 3-6, 2008 at Boston - The subjects that were highlighted were: immunology, vaccines (preclinical and clinical trials), virology (including other retroviruses), pathogenesis, neuropathogenesis and neurologic complications, antiretroviral therapy (preclinical, clinical randomized trials, clinical observational studies, and complications), therapeutic vaccines and immune-based therapies, primary/acute infection, clinical pharmacology, HIV drug resistance (including molecular mechanisms, clinical implications and epidemiology of HIV drug resistance), opportunistic infections (including tuberculosis), AIDS-related malignancies (e.g., lymphoma and kaposi's sarcoma), pediatrics/adolescents, maternal/fetal, HIV in women/women's health, novel diagnostic technologies and new monitoring tools, epidemiology of HIV infection, molecular epidemiology (including distribution and diversity of retroviruses), epidemiology of sexually transmitted diseases other than HIV, prevention studies (including microbicides and behavioral interventions), and research on clinical care and scale-up in developing countries (including operational research and implementation).
The Conference featured the thirteenth Annual Bernard Fields Memorial Lecture, the second N'Galy Mann Lecture, plenary lectures that were highly scientific in nature, roundtable symposia that presented and debated controversial scientific issues, several hundred original oral abstract and poster presentations of new data, and late breakers that  consisted of important preliminary research findings.
Text and graphic courtesy conference website. Additional resources courtesy The Body, a partner and Cooperating Organization with dgCommunity HIV/AIDS.